• Users Online: 114
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
TOPICAL REVIEW
Year : 2017  |  Volume : 12  |  Issue : 1  |  Page : 48-51

New treatments for systemic lupus erythematosus


Department of Medicine, Newark Beth Israel Medical Center, Rutgers, The NJ Medical School, Newark, New Jersey, USA

Correspondence Address:
Robert George Lahita
Rutgers, New Jersey Medical School, Newark, New Jersey
USA
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/injr.injr_1_17

Rights and Permissions

New therapies for systemic lupus erythematosus are rare. This is because of the complexity of the disease and its varied presentations. There are many variables and a variety of measurement scales that must be satisfied before a new agent is approved for use in humans. Attempts are ongoing to develop biological treatments for the disease using three approaches: B cell modulation, T cell regulation and cytokine inhibition. This paper reviews the current state of these three critical areas.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed989    
    Printed5    
    Emailed0    
    PDF Downloaded176    
    Comments [Add]    

Recommend this journal